Cointime

Fonds Vives II (University of Louvain, UCL)

investment firm

About

Fonds Vives II (University of Louvain, UCL)

Highlights

Investments
5
Exits
1

Details

Operating Status
Active

Investments

Number of Investments
Number of Lead Investments
5
0
Fonds Vives II (University of Louvain, UCL) has made 5 investments. Their most recent investment was on Dec 15, 2021, when Sunrise raised €6.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 15, 2021 Sunrise
Seed €6.50M Health Care —
May 28, 2020 Virovet
Series B €6M Biotechnology —
Jun 20, 2018 ITeos Therapeutics
Series B $75M Biotechnology —
Apr 27, 2018 A-Mansia Biotech
Series A €13M Biopharma —
May 3, 2012 ITeos Therapeutics
Series A €9M Biotechnology —

Exits

Fonds Vives II (University of Louvain, UCL) has had 1 exits. Fonds Vives II (University of Louvain, UCL) most notable exits include ITeos Therapeutics

Date Company Name Exit Type Industry
Jul 23, 2020 ITeos Therapeutics IPO Biotechnology Detail
Cointime
Chủ Đề
Công Ty